133 related articles for article (PubMed ID: 38574363)
1. Premature Ovarian Insufficiency After Coronavirus Disease 2019 (COVID-19): Autoimmune Follicle-Stimulating Hormone (FSH) and FSH Receptor Blockade.
Stern R; Bibi M; Keltz MD
Obstet Gynecol; 2024 Jun; 143(6):e149-e152. PubMed ID: 38574363
[TBL] [Abstract][Full Text] [Related]
2. Successful in vitro maturation of oocytes in a woman with gonadotropin-resistant ovary syndrome associated with a novel combination of FSH receptor gene variants: a case report.
Flageole C; Toufaily C; Bernard DJ; Ates S; Blais V; Chénier S; Benkhalifa M; Miron P
J Assist Reprod Genet; 2019 Mar; 36(3):425-432. PubMed ID: 30610662
[TBL] [Abstract][Full Text] [Related]
3. High levels of anti-SSA/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review : High levels of anti-SSA/Ro antibodies in COVID-19.
Fujii H; Tsuji T; Yuba T; Tanaka S; Suga Y; Matsuyama A; Omura A; Shiotsu S; Takumi C; Ono S; Horiguchi M; Hiraoka N
Clin Rheumatol; 2020 Nov; 39(11):3171-3175. PubMed ID: 32844364
[TBL] [Abstract][Full Text] [Related]
4. Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure.
Knauff EA; Eijkemans MJ; Lambalk CB; ten Kate-Booij MJ; Hoek A; Beerendonk CC; Laven JS; Goverde AJ; Broekmans FJ; Themmen AP; de Jong FH; Fauser BC;
J Clin Endocrinol Metab; 2009 Mar; 94(3):786-92. PubMed ID: 19066296
[TBL] [Abstract][Full Text] [Related]
5. [SARS-CoV-2 infection: implications for sexual and reproductive health. A position statement of the Asociación Española de Andrología, Medicina Sexual y Reproductiva (ASESA)].
José FG; González JGÁ; Molina JMC; Arnau LB; Iribarren IM; Jabaloyas JMM; Rico FM; García-Baquero R; Gayá MR; García EL; López CL; Castro RP; Salamanca JIM
Rev Int Androl; 2020; 18(3):117-123. PubMed ID: 32660697
[TBL] [Abstract][Full Text] [Related]
6. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).
Ngwenya O; Lensen SF; Vail A; Mol BWJ; Broekmans FJ; Wilkinson J
Cochrane Database Syst Rev; 2024 Jan; 1(1):CD012693. PubMed ID: 38174816
[TBL] [Abstract][Full Text] [Related]
7. Low molecular weight follicle-stimulating hormone receptor binding inhibitor in sera from premature ovarian failure patients.
Sluss PM; Schneyer AL
J Clin Endocrinol Metab; 1992 Jun; 74(6):1242-6. PubMed ID: 1592865
[TBL] [Abstract][Full Text] [Related]
8. The significance of elevated basal follicle stimulating hormone in regularly menstruating infertile women.
Ahmed Ebbiary NA; Lenton EA; Salt C; Ward AM; Cooke ID
Hum Reprod; 1994 Feb; 9(2):245-52. PubMed ID: 8027280
[TBL] [Abstract][Full Text] [Related]
9. Luteal phase stimulation in double ovarian stimulation cycles is not affected by the follicle-stimulating hormone (FSH) receptor genotype: double ovarian stimulation is beneficial independently of the genotype at position 680 of the follicle-stimulating hormone receptor.
Hortal M; Lledo B; Ortiz JA; Fuentes A; García-Ajofrín C; Romero R; Cascales A; Bernabeu A; Bernabeu R
Pharmacogenet Genomics; 2024 Jan; 34(1):1-7. PubMed ID: 37824400
[TBL] [Abstract][Full Text] [Related]
10. High-Dose Prednisone for Treatment of Autoimmune Pancreatitis in a Patient with Coronavirus Disease 2019 (COVID-19) due to Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Liaquat H; Shupp B; Kapoor S; Matin A
Am J Case Rep; 2020 Jul; 21():e926475. PubMed ID: 32692733
[TBL] [Abstract][Full Text] [Related]
11. Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function.
Barad DH; Weghofer A; Gleicher N
Obstet Gynecol; 2007 Jun; 109(6):1404-10. PubMed ID: 17540814
[TBL] [Abstract][Full Text] [Related]
12. Amenorrhea secondary to a vismodegib-induced blockade of follicle-stimulating hormone-receptor activation.
Strasswimmer J; Latimer B; Ory S
Fertil Steril; 2014 Aug; 102(2):555-7. PubMed ID: 24890268
[TBL] [Abstract][Full Text] [Related]
13. Maternal serum concentration of anti-Müllerian hormone is a better predictor than basal follicle stimulating hormone of successful blastocysts development during IVF treatment.
Sadruddin S; Barnett B; Ku L; Havemann D; Mucowski S; Herrington R; Burggren W
PLoS One; 2020; 15(10):e0239779. PubMed ID: 33044971
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
15. Does gonadotropin suppression result in follicular development in premature ovarian failure?
Buckler HM; Healy DL; Burger HG
Gynecol Endocrinol; 1993 Jun; 7(2):123-8. PubMed ID: 8213226
[TBL] [Abstract][Full Text] [Related]
16. The effect of 12-month dehydroepiandrosterone supplementation on the menstrual pattern, ovarian reserve markers, and safety profile in women with premature ovarian insufficiency.
Wong QHY; Yeung TWY; Yung SSF; Ko JKY; Li HWR; Ng EHY
J Assist Reprod Genet; 2018 May; 35(5):857-862. PubMed ID: 29520734
[TBL] [Abstract][Full Text] [Related]
17. Antibody tests for identification of current and past infection with SARS-CoV-2.
Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy despite imminent ovarian failure and extremely high endogenous gonadotropins and therapeutic strategies: case report and review.
Check ML; Check JH; Kaplan H
Clin Exp Obstet Gynecol; 2004; 31(4):299-301. PubMed ID: 15672973
[TBL] [Abstract][Full Text] [Related]
19. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Folegatti PM; Ewer KJ; Aley PK; Angus B; Becker S; Belij-Rammerstorfer S; Bellamy D; Bibi S; Bittaye M; Clutterbuck EA; Dold C; Faust SN; Finn A; Flaxman AL; Hallis B; Heath P; Jenkin D; Lazarus R; Makinson R; Minassian AM; Pollock KM; Ramasamy M; Robinson H; Snape M; Tarrant R; Voysey M; Green C; Douglas AD; Hill AVS; Lambe T; Gilbert SC; Pollard AJ;
Lancet; 2020 Aug; 396(10249):467-478. PubMed ID: 32702298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
